Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Shares Issued (2019 - 2025)

Historic Shares Issued for Revolution Medicines (RVMD) over the last 7 years, with Q3 2025 value amounting to $4.1 million.

  • Revolution Medicines' Shares Issued rose 3812.06% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $821.8 million, marking a year-over-year increase of 998246.84%. This contributed to the annual value of $823.0 million for FY2024, which is 15424.3% up from last year.
  • Revolution Medicines' Shares Issued amounted to $4.1 million in Q3 2025, which was up 3812.06% from $1.9 million recorded in Q2 2025.
  • Over the past 5 years, Revolution Medicines' Shares Issued peaked at $814.8 million during Q4 2024, and registered a low of -$564000.0 during Q2 2021.
  • For the 5-year period, Revolution Medicines' Shares Issued averaged around $120.2 million, with its median value being $2.5 million (2024).
  • As far as peak fluctuations go, Revolution Medicines' Shares Issued plummeted by 9989.17% in 2022, and later surged by 10603114.75% in 2023.
  • Quarter analysis of 5 years shows Revolution Medicines' Shares Issued stood at -$564000.0 in 2021, then surged by 44006.21% to $247.6 million in 2022, then crashed by 100.0% to $6000.0 in 2023, then soared by 13580716.67% to $814.8 million in 2024, then crashed by 99.49% to $4.1 million in 2025.
  • Its Shares Issued was $4.1 million in Q3 2025, compared to $1.9 million in Q2 2025 and $891000.0 in Q1 2025.